A detailed history of Ameritas Investment Partners, Inc. transactions in Nkarta, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 5,184 shares of NKTX stock, worth $12,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,184
Previous 5,184 -0.0%
Holding current value
$12,389
Previous $30,000 23.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.27 - $10.82 $14,508 - $29,787
2,753 Added 113.25%
5,184 $30,000
Q2 2022

Aug 12, 2022

BUY
$7.77 - $19.44 $10,295 - $25,758
1,325 Added 119.8%
2,431 $29,000
Q2 2021

Aug 06, 2021

SELL
$23.94 - $36.68 $13,167 - $20,174
-550 Reduced 33.21%
1,106 $35,000
Q1 2021

May 14, 2021

BUY
$31.33 - $59.61 $8,490 - $16,154
271 Added 19.57%
1,656 $54,000
Q3 2020

Nov 13, 2020

BUY
$23.52 - $47.9 $32,575 - $66,341
1,385 New
1,385 $42,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $116M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.